Yeast-Derived Pharmaceuticals & Advanced Recombinant Yeast Strains – Innovations in Biotechnology
Yeast, a versatile microorganism, has been instrumental in biotechnology, particularly in producing pharmaceuticals. The development of advanced recombinant yeast strains has revolutionized the industry, enabling efficient and cost-effective production of complex therapeutic compounds. 1. The Role of Yeast in Pharmaceutical Production Yeast-derived pharmaceuticals have gained prominence due to yeast's eukaryotic nature, which allows for proper protein folding and post-translational modifications essential for therapeutic efficacy. Yeast systems offer several advantages: ● Safety and Scalability : Yeast is generally recognized as safe (GRAS) and can be cultured on a large scale, facilitating mass production of pharmaceuticals. ● Cost-Effectiveness: Yeast grows rapidly on inexpensive media, reducing production costs. ● Genetic Manipulation: Yeast's genetic makeup is well-understood, allowing for precise...